These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9284796)

  • 61. Report on the 4th International Symposium of Ocular Inflammation.
    Wakefield D
    Ocul Immunol Inflamm; 1997 Mar; 5(1):1-9. PubMed ID: 9145687
    [No Abstract]   [Full Text] [Related]  

  • 62. Obstacles to prescribers' initiation early antiretroviral therapy: a barrier to achieving 90-90-90 goals.
    Medland NA; Mao L; Crooks L; de Wit J
    Lancet HIV; 2016 Dec; 3(12):e559-e560. PubMed ID: 27884374
    [No Abstract]   [Full Text] [Related]  

  • 63. From our consultation files. The challenge of neurosyphilis in HIV.
    Wilcox RD
    HIV Clin; 2009; 21(3):1, 5-6. PubMed ID: 19736645
    [No Abstract]   [Full Text] [Related]  

  • 64. Stopping anti-CMV therapy may be safe option for some HIV patients.
    Am J Health Syst Pharm; 2000 Jan; 57(1):21. PubMed ID: 10630552
    [No Abstract]   [Full Text] [Related]  

  • 65. [Disseminated infection due to Streptococcus constellatus in an HIV patient with negative viral load].
    Coll Crespo B; Pérez Bernalte RM; Alonso Villaverde Lozano C; Fernández Juliá R; Ballester Bastardie F; Masana Marín L
    An Med Interna; 2001 Dec; 18(12):660-1. PubMed ID: 11852510
    [No Abstract]   [Full Text] [Related]  

  • 66. Decline of infectious skin manifestations in the era of highly active antiretroviral therapy.
    Hengge UR; Franz B; Goos M
    AIDS; 2000 May; 14(8):1069-70. PubMed ID: 10853995
    [No Abstract]   [Full Text] [Related]  

  • 67. [Vaccinations and prophylaxis: what to consider].
    Härter G; Manfras BJ
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():38-42. PubMed ID: 27259901
    [No Abstract]   [Full Text] [Related]  

  • 68. AIDS-Related opportunistic illness and potent antiretroviral therapy.
    Engels EA; Frisch M; Biggar RJ; Goedert JJ
    JAMA; 2000 May 24-31; 283(20):2653-4. PubMed ID: 10819935
    [No Abstract]   [Full Text] [Related]  

  • 69. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.
    Price P; Morahan G; Huang D; Stone E; Cheong KY; Castley A; Rodgers M; McIntyre MQ; Abraham LJ; French MA
    AIDS; 2002 Oct; 16(15):2043-7. PubMed ID: 12370503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiretroviral therapy in adults.
    Wise B
    J Am Acad Nurse Pract; 1996 Jul; 8(7):329-41. PubMed ID: 9281977
    [No Abstract]   [Full Text] [Related]  

  • 71. Immune restoration following treatment. Abstract and Commentary.
    Landay AL
    JAMA; 1997 Nov; 278(18):1538. PubMed ID: 9411032
    [No Abstract]   [Full Text] [Related]  

  • 72. Report from the 17th Conference on Retroviruses and Opportunistic Infections. Non-AIDS-related adverse effects of HIV and its treatment.
    Sax PE
    J Watch AIDS Clin Care; 2010 Apr; 22(4):31. PubMed ID: 20480619
    [No Abstract]   [Full Text] [Related]  

  • 73. Preventive care for HIV-positive adults.
    Bachman DM
    JAMA; 1993 Aug; 270(5):577. PubMed ID: 8101232
    [No Abstract]   [Full Text] [Related]  

  • 74. Are anti-HIV drugs an effective treatment?
    Karpas A; Ash S; Bainbridge D
    Nat Med; 1997 Oct; 3(10):1052. PubMed ID: 9334698
    [No Abstract]   [Full Text] [Related]  

  • 75. Cytomegalovirus retinitis in a patient with a normal helper T-cell (CD4) count.
    Rahhal FM; Rosberger DF; Polsky B; Thoron L; Heinemann MH
    Arch Ophthalmol; 1993 Oct; 111(10):1325-6. PubMed ID: 8105772
    [No Abstract]   [Full Text] [Related]  

  • 76. Test, treat, and maintain: rapid initiation of antiretroviral therapy.
    Doshi RK; Greenberg AE
    AIDS; 2021 Sep; 35(11):1867-1869. PubMed ID: 34397486
    [No Abstract]   [Full Text] [Related]  

  • 77. Selected highlights from the 7th Annual Conference of the British HIV Association.
    Boyle BA
    AIDS Read; 2001 Jun; 11(6):299-302, 316. PubMed ID: 11449921
    [No Abstract]   [Full Text] [Related]  

  • 78. Cytomegalovirus-Immune Recovery Retinitis After Initiation of Highly Active Antiretroviral Therapy: A Case Series.
    Qian Y; Wang L; Jiang J; Suo J; Weng H; Che X; Lu H; Wang Z
    Front Med (Lausanne); 2022; 9():807013. PubMed ID: 35573011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV.
    Vinhaes CL; Araujo-Pereira M; Tibúrcio R; Cubillos-Angulo JM; Demitto FO; Akrami KM; Andrade BB
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.